CAD 0.03
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 426.38 Thousand CAD | 15.39% |
2022 | 369.51 Thousand CAD | 145.94% |
2021 | 150.24 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 249.19 Thousand CAD | -9.28% |
2024 Q3 | 273.6 Thousand CAD | 9.8% |
2024 Q1 | 274.67 Thousand CAD | -35.58% |
2023 Q3 | 371.24 Thousand CAD | -0.83% |
2023 FY | 426.38 Thousand CAD | 15.39% |
2023 Q1 | 289.41 Thousand CAD | -21.68% |
2023 Q2 | 374.35 Thousand CAD | 29.35% |
2023 Q4 | 426.38 Thousand CAD | 14.85% |
2022 Q3 | 347.71 Thousand CAD | 76.67% |
2022 FY | 369.51 Thousand CAD | 145.94% |
2022 Q4 | 369.51 Thousand CAD | 6.27% |
2022 Q1 | - CAD | -100.0% |
2022 Q2 | 196.81 Thousand CAD | 0.0% |
2021 Q4 | 150.24 Thousand CAD | 0.0% |
2021 FY | 150.24 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AI/ML Innovations Inc. | 1.53 Million CAD | 72.307% |
Pangenomic Health Inc. | 2.21 Million CAD | 80.76% |
nDatalyze Corp. | 38.26 Thousand CAD | -1014.428% |
Treatment.Com International Inc. | 1.47 Million CAD | 71.139% |
Unidoc Health Corp. | 2.38 Million CAD | 82.088% |